Literature DB >> 23269275

BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.

Yuan Liu1, Marty W Mayo, Alykhan S Nagji, Emily H Hall, Lisa S Shock, Aizhen Xiao, Edward B Stelow, David R Jones.   

Abstract

The mechanisms through which the metastasis suppressor gene BRMS1 functions are poorly understood. Herein, we report the identification of a previously undescribed E3 ligase function of BRMS1 on the histone acetyltransferase p300. BRMS1 induces polyubiquitination of p300, resulting in its proteasome-mediated degradation. We identify BRMS1 as the first eukaryote structural mimic of the bacterial IpaH E3 ligase family and establish that the evolutionarily conserved CXD motif located in BRMS1 is responsible for its E3 ligase function. Mutation of this E3 ligase motif not only abolishes BRMS1-induced p300 polyubiquitination and degradation, but importantly, dramatically reduces the metastasis suppressor function of BRMS1 in both in vitro and in vivo models of lung cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269275      PMCID: PMC3578176          DOI: 10.1158/0008-5472.CAN-12-2489

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.

Authors:  Stephen J Demarest; Maria Martinez-Yamout; John Chung; Hongwu Chen; Wei Xu; H Jane Dyson; Ronald M Evans; Peter E Wright
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

2.  Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.

Authors:  Qiao Li; Anna Su; Jihong Chen; Yvonne A Lefebvre; Robert J G Haché
Journal:  Mol Endocrinol       Date:  2002-12

3.  Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Authors:  Steven R Grossman; Maria E Deato; Chrystelle Brignone; Ho Man Chan; Andrew L Kung; Hideaki Tagami; Yoshihiro Nakatani; David M Livingston
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

4.  Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.

Authors:  Lalita A Shevde; Rajeev S Samant; Steven F Goldberg; Tabo Sikaneta; Alessandro Alessandrini; Henry J Donahue; David T Mauger; Danny R Welch
Journal:  Exp Cell Res       Date:  2002-02-15       Impact factor: 3.905

5.  Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.

Authors:  W L Kraus; E T Manning; J T Kadonaga
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.

Authors:  M J Seraj; R S Samant; M F Verderame; D R Welch
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

7.  Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Authors:  W Fischle; E Verdin; W C Greene
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

8.  Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription.

Authors:  C Poizat; V Sartorelli; G Chung; R A Kloner; L Kedes
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 9.  Breast cancer metastasis suppressor 1: update.

Authors:  William J Meehan; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinoma.

Authors:  Zhi-Wei Liao; Tong-Chong Zhou; Xiao-Jun Tan; Xian-Lu Song; Yuan Liu; Xing-Yuan Shi; Wen-Jin Huang; Li-Li Du; Bo-Jun Tu; Xiao-Dan Lin
Journal:  J Transl Med       Date:  2012-05-30       Impact factor: 5.531

View more
  20 in total

1.  Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.

Authors:  Yuan Liu; Marty W Mayo; Aizhen Xiao; Emily H Hall; Elianna B Amin; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Cdk2 regulates metastasis suppressor BRMS1.

Authors:  C E Caldon
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 3.  Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

Authors:  Chunbin Zou; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2014-01-03

4.  CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.

Authors:  Yuan Liu; Elianna B Amin; Marty W Mayo; Neel P Chudgar; Peter R Bucciarelli; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

5.  Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.

Authors:  Long Chen; Tingyi Wei; Xiaoxing Si; Qianqian Wang; Yan Li; Ye Leng; Anmei Deng; Jie Chen; Guiying Wang; Songcheng Zhu; Jiuhong Kang
Journal:  J Biol Chem       Date:  2013-03-29       Impact factor: 5.157

6.  Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity.

Authors:  H Karimi Kinyamu; Brian D Bennett; Pierre R Bushel; Trevor K Archer
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

7.  Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.

Authors:  Maria Chimonidou; Galatea Kallergi; Vassilis Georgoulias; Danny R Welch; Evi S Lianidou
Journal:  Mol Cancer Res       Date:  2013-06-06       Impact factor: 5.852

8.  MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.

Authors:  Yi Cao; Shengxing Tan; Yi Tu; Guoyang Zhang; Yi Liu; Daojiang Li; Shan Xu; Zhibiao Le; Jianbo Xiong; Wenyu Zou; Peitao Gong; Zhengrong Li; Zhigang Jie
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

9.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

10.  Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.

Authors:  Xueni Liu; Elphire Ehmed; Boyao Li; Jianming Dou; Xiaojing Qiao; Wenyong Jiang; Xi Yang; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.